Nutex Health Inc.
NUTX Healthcare Medical Care Facilities
Nutex Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $875.3 million, up 82.4% from fiscal 2024. In the quarter to June 2026, revenue fell 13.6%, EPS grew 424.8%, free cash flow grew 19.4% and total debt fell 1.69%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow NUTX
Nutex Health Inc. (NUTX) P/E ratio
As of 16 October 2026, Nutex Health Inc. (NUTX) trades at a P/E ratio of 7.1×. Over the past ten years it has ranged from 0.0× (December 2024) to 70.5× (April 2022); the current reading is higher than 67% of that period. That is below the Medical Care Facilities industry median of 20.6× and below the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 17.4× | 445.26% |
| FY2024 | 3.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 70.5× | 0.00% |
| FY2020 | 70.5× | 0.00% |
| FY2019 | 70.5× | 0.00% |
| FY2018 | 70.5× | 0.00% |
| FY2017 | 70.5× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 6.6× | (6.68%) |
| Mar 2026 | 7.0× | (59.56%) |
| Dec 2025 | 17.4× | 233.13% |
| Sep 2025 | 5.2× | (58.88%) |
| 39 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CMPS COMPASS Pathways PLC Sponsored ADR compare | n/m |
| INNV InnovAge Holding Corp. compare | n/m |
| AGL Agilon Health, Inc. compare | n/m |
| NUTX Nutex Health Inc. | 7.1× |
| HCSG Healthcare Services Group, Inc. compare | 12.2× |
| AMN AMN Healthcare Services Inc compare | 15.0× |
| ARDT Ardent Health, Inc. compare | 21.7× |
| PNTG The Pennant Group, Inc. compare | 44.5× |
| USPH U.S. Physical Therapy, Inc. compare | 504× |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)